Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes.
Multiple signaling pathways have been implicated in the hypertrophic response of ventricular myocytes, yet the importance of cell-matrix interactions has not been extensively examined. Integrins are cell-surface molecules that link the extracellular matrix to the cellular cytoskeleton. They can function as cell signaling molecules and transducers of mechanical information in noncardiac cells. Given these properties and their abundance in cardiac cells, we evaluated the hypothesis that beta1 integrin function is involved in the alpha1-adrenergic mediated hypertrophic response of neonatal rat ventricular myocytes. The hypertrophic response of this model required interaction with extracellular matrix proteins. Specificity of these results was confirmed by demonstrating that ventricular myocytes plated onto an anti-beta1 integrin antibody supported the hypertrophic gene response. Adenovirus-mediated overexpression of beta1 integrin augmented the myocyte hypertrophic response when assessed by protein synthesis and atrial natriuretic factor production, a marker gene of hypertrophic induction. DNA synthesis was not altered by integrin overexpression. Transfection of cultured cardiac myocytes with either the ubiquitously expressed beta1A integrin or the cardiac/skeletal muscle-specific beta1 isoform (beta1D) activated reporter expression from both the atrial natriuretic factor and myosin light chain-2 ventricular promoters, genetic markers of ventricular cell hypertrophy. Finally, suppression of integrin signaling by overexpression of free beta1 integrin cytoplasmic domains inhibited the adrenergically mediated atrial natriuretic factor response. These findings show that integrin ligation and signaling are involved in the cardiac hypertrophic response pathway.
Ross
R S
RS
Department of Physiology, UCLA School of Medicine, Los Angeles, Calif 90095-1751, USA. rross@physiology.medsch.ucla.edu
Pham
C
C
Shai
S Y
SY
Goldhaber
J I
JI
Fenczik
C
C
Glembotski
C C
CC
Ginsberg
M H
MH
Loftus
J C
JC
D000256:Adenoviridae; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D009320:Atrial Natriuretic Factor / Q000032:analysis; D006332:Cardiomegaly / Q000473:pathology / Q000503:physiopathology*; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism; D015967:Gene Expression Regulation, Viral / Q000502:physiology; D006352:Heart Ventricles / Q000737:chemistry / Q000473:pathology; D019012:Integrin beta1 / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D007536:Isomerism; D009206:Myocardium / Q000737:chemistry* / Q000473:pathology; D010656:Phenylephrine / Q000494:pharmacology; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000502:physiology*; D014162:Transfection
D000316:Adrenergic alpha-Agonists; D019012:Integrin beta1; D010656:Phenylephrine; D009320:Atrial Natriuretic Factor